Breaking News Instant updates and real-time market news.

ABUS

Arbutus Biopharma

$5.90

0.25 (4.42%)

05:30
02/15/18
02/15
05:30
02/15/18
05:30

Arbutus Biopharma enters exclusivity agreement with Roivant Sciences

Arbutus Biopharma announced that Arbutus and Roivant entered into an exclusivity agreement providing for a period that expires on March 15, 2018. Pursuant to the Exclusivity Agreement, during this period, Arbutus and Roivant agree to negotiate on an exclusive basis the terms and conditions of a proposal to jointly develop Arbutus' nucleic acid delivery platform based on its Lipid Nanoparticle, or LNP, technology and GalNAc technology, or collectively, Delivery Technologies, through a new company that would jointly own, manage, and develop the Delivery Technologies. There are no assurances that Arbutus and Roivant will reach an agreement regarding any such transaction or that any such transaction will be consummated.

ABUS Arbutus Biopharma
$5.90

0.25 (4.42%)

03/03/17
WBLR
03/03/17
NO CHANGE
WBLR
HBV space to consolidate over next five years, says William Blair
William Blair analyst Y. Katherine Xu sees curing chronic hepatitis B virus infections as "the next frontier" after the success of hepatitis C treatments and believes the market for an HBV cure could be "similar in size to that of HCV," or $200B in cumulative global sales over a span of two decades. She expects consolidation of the HBV market over the next five years, much like what happened with the HCV market. Xu sees Spring Bank Pharmaceuticals (SBPH) and Arbutus (ABUS) as having the strongest data catalysts in 2017, followed by Assembly Biosciences (ASMB) and Arrowhead (ARWR). She has Outperform ratings on the first three stocks and a Market Perform rating on Arrowhead.
04/04/17
CHDN
04/04/17
UPGRADE
Target $6
CHDN
Buy
Arbutus Biopharma upgraded to Buy from Neutral at Chardan
Chardan analyst Madhu Kumar upgraded Arbutus Biopharma to Buy, raising his price target to $6 from $3. Kumar thinks HBV therapy represents a significant market in infectious disease as multiple RNAi drugs have demonstrated clinical proof of concept for hepatitis B surface antigen suppression, and early HBV combination clinical data looks promising.
10/03/17
JMPS
10/03/17
NO CHANGE
Target $13
JMPS
Outperform
Arbutus well positioned to accelerate pipeline growth, says JMP Securities
JMP Securities analyst Liisa Bayko said she believes Arbutus Biopharma is well positioned to accelerate its pipeline growth after striking a deal for additional funding from Roivant Sciences. The analyst, who continues to recommend Arbutus shares as the company approaches key inflection points, keeps an Outperform rating on the stock and raised her price target to $13 from $12 to reflect the near-term cash from the Roivant agreement.
01/05/18
RILY
01/05/18
INITIATION
Target $10
RILY
Buy
Arbutus Biopharma initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Madhu Kumar started Arbutus Biopharma with a Buy rating and $10 price target.

TODAY'S FREE FLY STORIES

IYT

iShares Transportation Average

$174.71

-2.84 (-1.60%)

08:20
12/14/18
12/14
08:20
12/14/18
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:20
12/14/18
12/14
08:20
12/14/18
08:20
General news
U.S. retail sales preview: »

U.S. retail sales…

XLK

Technology Select Sector SPDR

$66.18

0.1 (0.15%)

08:19
12/14/18
12/14
08:19
12/14/18
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$63.56

0.23 (0.36%)

08:19
12/14/18
12/14
08:19
12/14/18
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$104.08

-0.48 (-0.46%)

08:19
12/14/18
12/14
08:19
12/14/18
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$51.74

-0.6 (-1.15%)

08:19
12/14/18
12/14
08:19
12/14/18
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$56.94

0.49 (0.87%)

08:18
12/14/18
12/14
08:18
12/14/18
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AY

Atlantica Yield

$20.00

0.1 (0.50%)

08:18
12/14/18
12/14
08:18
12/14/18
08:18
Hot Stocks
Atlantica Yield acquires 50 MW wind plant in Uruguay for $45M »

Atlantica Yield announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$55.48

0.36 (0.65%)

08:18
12/14/18
12/14
08:18
12/14/18
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$92.04

0.06 (0.07%)

08:18
12/14/18
12/14
08:18
12/14/18
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETFC

E-Trade

$44.26

-1.36 (-2.98%)

08:17
12/14/18
12/14
08:17
12/14/18
08:17
Hot Stocks
E-Trade reports November DARTs up 11% y/y »

E*TRADE Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$142.79

-2.02 (-1.39%)

08:17
12/14/18
12/14
08:17
12/14/18
08:17
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$246.38

0.54 (0.22%)

08:17
12/14/18
12/14
08:17
12/14/18
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$265.41

-0.12 (-0.05%)

08:17
12/14/18
12/14
08:17
12/14/18
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$24.49

-0.14 (-0.57%)

08:17
12/14/18
12/14
08:17
12/14/18
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$92.11

-0.32 (-0.35%)

08:16
12/14/18
12/14
08:16
12/14/18
08:16
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

Invesco QQQ Trust

$165.11

0.08 (0.05%)

08:16
12/14/18
12/14
08:16
12/14/18
08:16
Technical Analysis
Invesco QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$66.90

0.8 (1.21%)

08:16
12/14/18
12/14
08:16
12/14/18
08:16
Recommendations
Starbucks analyst commentary  »

Starbucks EPS view reset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

EME

Emcor

$64.78

-1.07 (-1.62%)

08:16
12/14/18
12/14
08:16
12/14/18
08:16
Initiation
Emcor initiated  »

Emcor initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$COMP

Nasdaq Composite

$0.00

(0.00%)

08:16
12/14/18
12/14
08:16
12/14/18
08:16
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDX

Nasdaq 100 Index

$0.00

(0.00%)

08:16
12/14/18
12/14
08:16
12/14/18
08:16
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPG

PPG

$100.85

-2.62 (-2.53%)

08:15
12/14/18
12/14
08:15
12/14/18
08:15
Hot Stocks
PPG to acquire Whitford Worldwide, terms not disclosed »

PPG announced that it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:15
12/14/18
12/14
08:15
12/14/18
08:15
Conference/Events
JPMorgan to hold a forum »

China & Hong Kong…

ASPU

Aspen Group

$5.13

-0.43 (-7.73%)

08:15
12/14/18
12/14
08:15
12/14/18
08:15
Conference/Events
Aspen Group management to meet with Lake Street »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

08:15
12/14/18
12/14
08:15
12/14/18
08:15
General news
Retail Sales less autos to be reported at 08:30 »

November Retail Sales…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.